PHARMACOR ROXITHROMYCIN Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor roxithromycin

apotex pty ltd - roxithromycin -

CLARITHYROMYCIN 125/5 Mg/Ml Granules for Oral Suspension Ireland - English - HPRA (Health Products Regulatory Authority)

clarithyromycin 125/5 mg/ml granules for oral suspension

rowex ltd - clarithromycin - granules for oral suspension - 125/5 mg/ml

CLARITHYROMYCIN 250/5 Mg/Ml Granules for Oral Suspension Ireland - English - HPRA (Health Products Regulatory Authority)

clarithyromycin 250/5 mg/ml granules for oral suspension

rowex ltd - clarithromycin - granules for oral suspension - 250/5 mg/ml

EES erythromycin 200mg/5mL (as ethyl succinate) granules for oral liquid bottle Australia - English - Department of Health (Therapeutic Goods Administration)

ees erythromycin 200mg/5ml (as ethyl succinate) granules for oral liquid bottle

amdipharm mercury australia pty ltd - erythromycin ethyl succinate -

EES erythromycin (as ethyl succinate) 400mg/5mL granules for oral liquid bottle Australia - English - Department of Health (Therapeutic Goods Administration)

ees erythromycin (as ethyl succinate) 400mg/5ml granules for oral liquid bottle

amdipharm mercury australia pty ltd - erythromycin ethyl succinate -

ROXY TABLET 150MG Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

roxy tablet 150mg

imeks pharma sdn. bhd. - roxithromycin -

ROXITHROMYCIN - HEXAL 150 mg South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

roxithromycin - hexal 150 mg

hexal -

CLARITHYROMYCIN Granules for Oral Suspension 125/5 Mg/Ml Ireland - English - HPRA (Health Products Regulatory Authority)

clarithyromycin granules for oral suspension 125/5 mg/ml

rowex ltd - clarithromycin - granules for oral suspension - 125/5 mg/ml

CLARITHYROMYCIN Granules for Oral Suspension 250/5 Mg/Ml Ireland - English - HPRA (Health Products Regulatory Authority)

clarithyromycin granules for oral suspension 250/5 mg/ml

rowex ltd - clarithromycin - granules for oral suspension - 250/5 mg/ml

BIAXSIG 300mg blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

biaxsig 300mg blister pack

sanofi-aventis australia pty ltd - roxithromycin, quantity: 300 mg - tablet, film coated - excipient ingredients: purified talc; colloidal anhydrous silica; hypromellose; titanium dioxide; magnesium stearate; povidone; hyprolose; glucose; maize starch; propylene glycol; poloxamer - for the treatment of mild to moderately severe infections in adults caused by or likely to be caused by susceptible micro-organisms in; acute pharyngitis, tonsillitis, and sinusitis. acute bronchitis and acute exacerbations of chronic bronchitis; community acquired pneumonia (including atypical pneumonia). skin and soft tissue infections and non-gonococcal urethritis